Screade® | Exclusive | FDA Gives Third Rare-Disease Drug Another Shot,

BusinessPets

Exclusive | FDA Gives Third Rare-Disease Drug Another Shot, Regenxbio Says - WSJ

Company plans to refile its application for its gene therapy for a fatal brain disease after FDA dropped demands to give a placebo to some study subjects

Comments